Report Highlights
The global market for medical ultrasound devices will grow from $6.7 billion in 2018 to $7.8 billion by 2023 with a compound annual growth rate (CAGR) of 3.0% for the period of 2018-2023.
Report Includes
- 42 data tables and 19 additional tables
- An overview of the global medical ultrasound device market
- Analyses of global market trends, with data from 2016, 2017, estimates for 2018 and projections of CAGRs through 2023
- Description of two-dimensional (2D), 3D and 4D ultrasound and discussion of their significant impact in the clinical arena
- Information on doppler ultrasound, and high-intensity focused ultrasound (HIFU)
- Detailed analysis of the key competitor engaged in the market, including Alpinion Medical Systems, Echo Medical Control (ECM), Philips Healthcare Company, Siemens Healthcare Private Limited, Telemed Ltd.
Report Scope
The current report provides detailed exposure to the medical ultrasound device market. The focus of the current report is to provide an in-depth analysis of the clinical application of ultrasound equipment, and also the current and future market potentials for ultrasound devices. The report provides a detailed analysis of the market trends, drivers and restraints by region for medical ultrasound devices. Since this report is on medical ultrasound, only medical/clinical applications are considered here. Non-clinical applications are not part of this report.
The report also covers competition analysis, regulatory environment, latest technology developments and market share by application, as well as market projections to 2023. The report details market shares of medical ultrasound devices by diagnostics (2D, 3D and 4D ultrasound, Doppler ultrasound), and therapeutics (High-intensity focused ultrasound [HIFU] and extracorporeal shockwave therapy) segments. By application, the market is segmented into radiology/general imaging, cardiology, obstetrics/gynecology, urogenital, breast imaging, anesthesia and other emerging applications.
Also covered in the current report is an in-depth analysis of market drivers, restraints and microeconomic factors affecting the growth of medical ultrasound devices by region (regions include North America, Europe, Asia-pacific, Latin America, and Middle East and Africa). Global market shares, with special emphasis on the latest technology developed is included in this report. For market estimates, data has been provided for the year 2017, as the base year, 2018 and forecast for 2023.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Advanced Materials for Extreme Environments: Global Markets (AVM198B)
- Rare Disease Diagnostics: Technologies and Global Markets (PHM227B)
- Breakthrough Therapies: Market Dynamics and Investment Opportunities (PHM176B)
- Green Hydrogen: Global Markets (ENV060B)
- Softgel Capsules: Global Markets (PHM244B)
Related Reports
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Endoscopy Devices: Applications and Global Markets
The global market for endoscopy devices is estimated to increase from $51.7 billion in 2022 to reach $75.9 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Global Nuclear Imaging Equipment Market
The global nuclear imaging equipment market should reach $4.9 billion by 2026 from $3.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.7% for the forecast period of 2021 to 2026.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More